India Capital Growth (IGC) Competitors GBX 177.50 0.00 (0.00%) As of 07/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock IGC vs. SLN, AMYT, BMY, OGN, GPH, AURA, ARTL, PHAR, ORPH, and AMPHShould you be buying India Capital Growth stock or one of its competitors? The main competitors of India Capital Growth include Silence Therapeutics (SLN), Amryt Pharma (AMYT), Bloomsbury Publishing (BMY), Origin Enterprises (OGN), Global Ports (GPH), Aura Energy (AURA), Alpha Real Trust (ARTL), Pharos Energy (PHAR), Open Orphan (ORPH), and Aggregated Micro Power (AMPH). These companies are all part of the "pharmaceutical products" industry. India Capital Growth vs. Its Competitors Silence Therapeutics Amryt Pharma Bloomsbury Publishing Origin Enterprises Global Ports Aura Energy Alpha Real Trust Pharos Energy Open Orphan Aggregated Micro Power India Capital Growth (LON:IGC) and Silence Therapeutics (LON:SLN) are both small-cap pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends. Does the media refer more to IGC or SLN? In the previous week, Silence Therapeutics' average media sentiment score of 0.00 beat India Capital Growth's score of -0.52 indicating that Silence Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment India Capital Growth Negative Silence Therapeutics Neutral Which has better valuation & earnings, IGC or SLN? India Capital Growth has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than India Capital Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIndia Capital Growth£46.21M3.32£43.14M£49.523.58Silence Therapeutics£11.35M0.00N/A-£48.60N/A Do insiders and institutionals have more ownership in IGC or SLN? 24.3% of India Capital Growth shares are held by institutional investors. 0.2% of India Capital Growth shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is IGC or SLN more profitable? India Capital Growth has a net margin of 93.35% compared to Silence Therapeutics' net margin of 0.00%. India Capital Growth's return on equity of 25.12% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets India Capital Growth93.35% 25.12% 15.98% Silence Therapeutics N/A N/A N/A SummaryIndia Capital Growth beats Silence Therapeutics on 8 of the 9 factors compared between the two stocks. Get India Capital Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for IGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IGC vs. The Competition Export to ExcelMetricIndia Capital GrowthAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£153.25M£1.25B£6.44B£2.96BDividend YieldN/A4.36%4.17%5.02%P/E Ratio3.5821.8113.50147.85Price / Sales3.322,406.101,784.43258,997.79Price / Cash97.3160.8148.8627.97Price / Book0.891.213.175.27Net Income£43.14M£264.68M£1.25B£5.90B7 Day Performance2.01%0.37%0.57%1.04%1 Month Performance3.80%2.71%3.29%5.13%1 Year Performance-4.36%6.53%15.35%80.73% India Capital Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IGCIndia Capital GrowthN/AGBX 177.50flatN/A-3.5%£153.25M£46.21M3.5861SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownBMYBloomsbury Publishing3.0043 of 5 starsGBX 490-2.4%GBX 825+68.4%-23.6%£395.40M£382.40M10.4834,300News CoverageOGNOrigin EnterprisesN/AGBX 3.70+0.7%N/A+15.7%£390.67M£183.08B10.7010,000Dividend IncreaseGPHGlobal PortsN/AN/AN/AN/A£231.21M£193.58M30,000.0020AURAAura EnergyN/AGBX 8.10+1.2%N/A+2.1%£145.55MN/A-17,750.9950ARTLAlpha Real TrustN/AN/AN/AN/A£113.12M£8.46M96.445Gap UpHigh Trading VolumePHARPharos EnergyN/AGBX 21.90+4.3%N/A-12.9%£109.25M£196.07M-2.33280Positive NewsORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179Positive NewsAMPHAggregated Micro PowerN/AN/AN/AN/A£64.54M£49.33M70.771,620Gap Up Related Companies and Tools Related Companies Silence Therapeutics Competitors Amryt Pharma Competitors Bloomsbury Publishing Competitors Origin Enterprises Competitors Global Ports Competitors Aura Energy Competitors Alpha Real Trust Competitors Pharos Energy Competitors Open Orphan Competitors Aggregated Micro Power Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IGC) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding India Capital Growth Please log in to your account or sign up in order to add this asset to your watchlist. Share India Capital Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.